Magnetic Resonance Imaging (MRI) Contrast Agents Global Market Report 2026

Description

Magnetic resonance imaging (MRI) contrast agents are substances used to improve the clarity of internal body structures during MRI scans by modifying the local magnetic environment of tissues. They primarily function by influencing the relaxation times of nearby hydrogen nuclei, which alters the signal intensity in the resulting images. These agents enhance the distinction between healthy and abnormal tissues, supporting more precise anatomical and disease evaluation.

The primary products of magnetic resonance imaging (MRI) contrast agents include super-paramagnetic agents and paramagnetic agents. Super-paramagnetic agents refer to contrast media that enhance imaging by modifying magnetic properties, thereby improving the visibility of specific tissues and structures during MRI procedures. These agents are administered through intravenous administration, oral administration, and intra-articular administration routes. They are applied in gastrointestinal imaging, intravenous imaging, hepato-biliary imaging, neurological imaging, and other diagnostic areas, and are used by end users including hospitals, diagnostic and imaging centres, research institutes, and other healthcare facilities.

Tariffs are impacting the magnetic resonance imaging contrast agents market by raising the cost of raw materials such as gadolinium and iron oxide compounds, which in turn increases production expenses for manufacturers. These cost pressures are especially affecting segments like super-paramagnetic agents and paramagnetic agents, while hospitals and diagnostic imaging centers are facing higher procurement costs. Regions that rely heavily on imports, particularly Asia-Pacific and emerging markets, are experiencing supply chain disruptions and pricing instability. However, tariffs are also driving local manufacturing, strengthening regional production capabilities, and reducing long-term dependence on imported supplies.

The magnetic resonance imaging (MRI) contrast agents market research report is one of a series of new reports from The Business Research Company that provides magnetic resonance imaging (MRI) contrast agents market statistics, including magnetic resonance imaging (MRI) contrast agents industry global market size, regional shares, competitors with a magnetic resonance imaging (MRI) contrast agents market share, detailed magnetic resonance imaging (MRI) contrast agents market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (MRI) contrast agents industry. This magnetic resonance imaging (MRI) contrast agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The magnetic resonance imaging (MRI) contrast agents market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.64 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising incidence of chronic diseases, growth in diagnostic imaging infrastructure, increased healthcare expenditure, expansion of hospital networks, advancements in mri technology.

The magnetic resonance imaging (MRI) contrast agents market size is expected to see strong growth in the next few years. It will grow to $2.17 billion by 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to development of targeted contrast agents, increasing demand for precision diagnostics, growth in outpatient imaging centers, technological innovation in contrast formulations, rising awareness of early disease detection. Major trends in the forecast period include increasing adoption of gadolinium-based contrast agents, growing demand for safer and low-toxicity agents, rising prevalence of neurological and gastrointestinal disorders, advancements in nanoparticle-based contrast agents, expanding use of mri in diagnostic imaging centers.

The rising prevalence of chronic disease is anticipated to propel the growth of the magnetic resonance imaging (MRI) contrast agents market in coming years. A chronic disease is a long-lasting health condition that progresses slowly and usually persists for years. Chronic diseases are increasing due to unhealthy lifestyle habits such as poor diet and physical inactivity. Magnetic resonance imaging (MRI) contrast agents are used in chronic diseases to enhance visualization of tissues and abnormalities, enabling accurate diagnosis, monitoring of disease progression, and assessment of treatment response. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK are living with cancer, a figure projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising prevalence of chronic disease is driving the growth of the magnetic resonance imaging (MRI) contrast agents market.

Leading companies operating in the magnetic resonance imaging (MRI) contrast agents market are focusing on developing innovative products such as iron-based contrast agents to provide safer alternatives for patients with kidney issues and enhance imaging accuracy. Iron-based contrast agents are MRI agents containing superparamagnetic iron oxide nanoparticles that enhance image contrast by altering local magnetic fields, helping improve tumor and lesion visualization while offering a safer alternative for patients with kidney impairment. For example, in February 2026, Azurity Pharmaceuticals, a U. S. -based pharmaceutical company, launched Ferabright, an iron-based contrast agent approved by the U. S. Food and Drug Administration (FDA) for MRI of the brain in adults with known or suspected malignant neoplasms. Ferabright is supplied in single-dose vials of 300 mg or 510 mg elemental iron per intravenous infusion, designed to improve visualization of brain lesions with disrupted blood-brain barriers. Its large molecular size allows it to remain intravascular during early imaging phases, and delayed-phase MRI highlights tumor enhancement through macrophage uptake. Additionally, Ferabright is processed via natural iron metabolism, reducing concerns about long-term retention and providing an alternative for patients who cannot receive gadolinium, while supporting environmentally sustainable imaging practices.

In September 2024, Viwit Pharmaceutical Co. Ltd., a China-based biopharmaceutical company, entered into a partnership with Zydus Lifesciences Ltd. to strengthen and expand its presence in the US market through the commercialization of generic gadolinium-based MRI contrast agents. With this collaboration, Viwit Pharmaceutical Co. Ltd. utilized Zydus Lifesciences Ltd. 's well-established marketing, distribution, and commercialization strengths to speed up the adoption of its generic gadolinium-based MRI contrast agents and broaden its reach across the U. S. healthcare ecosystem, including hospitals, diagnostic imaging centers, and specialty clinics. Zydus Lifesciences Ltd. is an India-based healthcare company that offers a wide and diverse range of therapies, including oncology treatments, generic medicines, and specialty pharmaceutical products.

Major companies operating in the magnetic resonance imaging (mri) contrast agents market are Bayer AG, GE HealthCare Technologies Inc., Hengrui Medicine Co. Ltd., Zydus Lifesciences Ltd., Bracco Imaging S. p. A., Lantheus Holdings Inc., Guerbet SA, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Azurity Pharmaceuticals Inc., Yangtze River Pharmaceutical Group Co. Ltd., Beijing Beilu Pharmaceutical Co. Ltd., Unijules Life Sciences Ltd., Viwit Pharmaceutical Co. Ltd., Sanochemia Pharmazeutika AG, J. B. Chemicals & Pharmaceuticals Ltd., Nano Therapeutics Pvt. Ltd., Taejoon Pharm Co. Ltd., Nanoprobes Inc., Spago Nanomedical AB, Advanced Magnetics Inc

North America was the dominating region in the magnetic resonance imaging (MRI) contrast agents market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the magnetic resonance imaging (MRI) contrast agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the magnetic resonance imaging (MRI) contrast agents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The magnetic resonance imaging (MRI) contrast agents market consists of sales of gadolinium-based contrast agents, iron oxide nanoparticles, manganese-based agents, and other paramagnetic or superparamagnetic imaging compounds. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Magnetic Resonance Imaging (MRI) Contrast Agents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses magnetic resonance imaging (mri) contrast agents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for magnetic resonance imaging (mri) contrast agents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The magnetic resonance imaging (mri) contrast agents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product: Super-Paramagnetic Agents; Paramagnetic Agents
2) By Route Of Administration: Oral Administration; Intra Articular Administration
3) By Application: Gastrointestinal; Intravenous; Hepato-Biliary; Neurological Imaging; Other Applications
4) By End-Use: Hospitals; Diagnostic And Imaging Centres; Research Institutes; Other End-Users
Subsegments:
1) By Super-Paramagnetic Agents: Iron Oxide Nanoparticles; Ultrasmall Superparamagnetic Iron Oxide Particles; Standard Superparamagnetic Iron Oxide Particles; Liver Targeted Superparamagnetic Agents
2) By Paramagnetic Agents: Gadolinium Based Contrast Agents; Manganese Based Contrast Agents; Macrocyclic Paramagnetic Agents; Linear Paramagnetic Agents
Companies Mentioned: Bayer AG; GE HealthCare Technologies Inc.; Hengrui Medicine Co. Ltd.; Zydus Lifesciences Ltd.; Bracco Imaging S.p.A.; Lantheus Holdings Inc.; Guerbet SA; Jiangsu Hengrui Pharmaceuticals Co. Ltd.; Azurity Pharmaceuticals Inc.; Yangtze River Pharmaceutical Group Co. Ltd.; Beijing Beilu Pharmaceutical Co. Ltd.; Unijules Life Sciences Ltd.; Viwit Pharmaceutical Co. Ltd.; Sanochemia Pharmazeutika AG; J.B. Chemicals & Pharmaceuticals Ltd.; Nano Therapeutics Pvt. Ltd.; Taejoon Pharm Co. Ltd.; Nanoprobes Inc.; Spago Nanomedical AB; Advanced Magnetics Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: MC5MMREF02_G26Q2

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Magnetic Resonance Imaging (MRI) Contrast Agents Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Magnetic Resonance Imaging (MRI) Contrast Agents Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Sustainability, Climate Tech & Circular Economy
- 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Gadolinium-Based Contrast Agents
- 4.2.2 Growing Demand For Safer And Low-Toxicity Agents
- 4.2.3 Rising Prevalence Of Neurological And Gastrointestinal Disorders
- 4.2.4 Advancements In Nanoparticle-Based Contrast Agents
- 4.2.5 Expanding Use Of MRI In Diagnostic Imaging Centers

5. Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Diagnostic And Imaging Centres
5.3 Research Institutes
5.4 Pharmaceutical And Biotechnology Companies
5.5 Other End Users

6. Magnetic Resonance Imaging (MRI) Contrast Agents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Magnetic Resonance Imaging (MRI) Contrast Agents Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Magnetic Resonance Imaging (MRI) Contrast Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size, Comparisons And Growth Rate Analysis
7.3. Global Magnetic Resonance Imaging (MRI) Contrast Agents Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Magnetic Resonance Imaging (MRI) Contrast Agents Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Magnetic Resonance Imaging (MRI) Contrast Agents Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Magnetic Resonance Imaging (MRI) Contrast Agents Market Segmentation

9.1. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Super-Paramagnetic Agents, Paramagnetic Agents
9.2. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral Administration, Intra Articular Administration
9.3. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gastrointestinal, Intravenous, Hepato-Biliary, Neurological Imaging, Other Applications
9.4. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Diagnostic And Imaging Centres, Research Institutes, Other End Users
9.5. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Sub-Segmentation Of Super-Paramagnetic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Iron Oxide Nanoparticles, Ultrasmall Superparamagnetic Iron Oxide Particles, Standard Superparamagnetic Iron Oxide Particles, Liver Targeted Superparamagnetic Agents
9.6. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Sub-Segmentation Of Paramagnetic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gadolinium Based Contrast Agents, Manganese Based Contrast Agents, Macrocyclic Paramagnetic Agents, Linear Paramagnetic Agents

10. Magnetic Resonance Imaging (MRI) Contrast Agents Market Regional And Country Analysis

10.1. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market

11.1. Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Magnetic Resonance Imaging (MRI) Contrast Agents Market

12.1. China Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Magnetic Resonance Imaging (MRI) Contrast Agents Market

13.1. India Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Magnetic Resonance Imaging (MRI) Contrast Agents Market

14.1. Japan Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Magnetic Resonance Imaging (MRI) Contrast Agents Market

15.1. Australia Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Magnetic Resonance Imaging (MRI) Contrast Agents Market

16.1. Indonesia Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market

17.1. South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Magnetic Resonance Imaging (MRI) Contrast Agents Market

18.1. Taiwan Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market

19.1. South East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market

20.1. Western Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Magnetic Resonance Imaging (MRI) Contrast Agents Market

21.1. UK Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Magnetic Resonance Imaging (MRI) Contrast Agents Market

22.1. Germany Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Magnetic Resonance Imaging (MRI) Contrast Agents Market

23.1. France Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Magnetic Resonance Imaging (MRI) Contrast Agents Market

24.1. Italy Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Magnetic Resonance Imaging (MRI) Contrast Agents Market

25.1. Spain Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market

26.1. Eastern Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Magnetic Resonance Imaging (MRI) Contrast Agents Market

27.1. Russia Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Magnetic Resonance Imaging (MRI) Contrast Agents Market

28.1. North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Magnetic Resonance Imaging (MRI) Contrast Agents Market

29.1. USA Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Magnetic Resonance Imaging (MRI) Contrast Agents Market

30.1. Canada Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Magnetic Resonance Imaging (MRI) Contrast Agents Market

31.1. South America Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Magnetic Resonance Imaging (MRI) Contrast Agents Market

32.1. Brazil Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Magnetic Resonance Imaging (MRI) Contrast Agents Market

33.1. Middle East Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market

34.1. Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Magnetic Resonance Imaging (MRI) Contrast Agents Market Regulatory and Investment Landscape

36. Magnetic Resonance Imaging (MRI) Contrast Agents Market Competitive Landscape And Company Profiles

36.1. Magnetic Resonance Imaging (MRI) Contrast Agents Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Magnetic Resonance Imaging (MRI) Contrast Agents Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Magnetic Resonance Imaging (MRI) Contrast Agents Market Company Profiles
- 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Hengrui Medicine Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Zydus Lifesciences Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Bracco Imaging S.p.A. Overview, Products and Services, Strategy and Financial Analysis

37. Magnetic Resonance Imaging (MRI) Contrast Agents Market Other Major And Innovative Companies

Lantheus Holdings Inc., Guerbet SA, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Azurity Pharmaceuticals Inc., Yangtze River Pharmaceutical Group Co. Ltd., Beijing Beilu Pharmaceutical Co. Ltd., Unijules Life Sciences Ltd., Viwit Pharmaceutical Co. Ltd., Sanochemia Pharmazeutika AG, J.B. Chemicals & Pharmaceuticals Ltd., Nano Therapeutics Pvt. Ltd., Taejoon Pharm Co. Ltd., Nanoprobes Inc., Spago Nanomedical AB, Advanced Magnetics Inc

38. Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Magnetic Resonance Imaging (MRI) Contrast Agents Market

41. Magnetic Resonance Imaging (MRI) Contrast Agents Market High Potential Countries, Segments and Strategies

41.1 Magnetic Resonance Imaging (MRI) Contrast Agents Market In 2030 - Countries Offering Most New Opportunities
41.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market In 2030 - Segments Offering Most New Opportunities
41.3 Magnetic Resonance Imaging (MRI) Contrast Agents Market In 2030 - Growth Strategies
- 41.3.1 Market Trend Based Strategies
- 41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer